Craig-Hallum Downgrades Quotient Technology to Hold
Craig-Hallum analyst Chad Bennett downgrades Quotient Technology (NYSE:QUOT) from Buy to Hold.
Quotient Technology Q2 EPS $(0.45) Down From $(0.18) YoY, Sales $69.30M Miss $78.46M Estimate
Quotient Technology (NYSE:QUOT) reported quarterly losses of $(0.45) per share. This is a 150 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 326 stocks hit new 52-week lows.
12 Consumer Discretionary Stocks Moving In Monday’s After-Market Session
Gainers
Tuesday Morning (NASDAQ:TUEM) shares moved upwards by 12.8% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $33.9 million.
Quotient Technology’s Return On Capital Employed Overview
Benzinga Pro data, Quotient Technology (NYSE:QUOT) reported Q1 sales of $78.46 million. Earnings fell to a loss of $26.31 million, resulting in a 269.99% decrease from last quarter.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
